Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483574
Status:
COMPLETED
Last Update Posted:
2016-05-16
First Post:
2007-06-06
Brief Title:
Study of the Safety of Menactra Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Study Overview
Official Title:
Safety Study of Menactra Meningococcal Groups A C Y and W-135 Polysaccharide Diphtheria Toxoid Conjugate Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial will evaluate the safety of two injections of Menactra Vaccine in subjects at 9 months and at 12 months of age when the second dose is given concomitantly with other pediatric vaccines routinely administered in the US
Safety Objective
To describe the safety profile of two doses of Menactra Vaccine
Safety Objective
To describe the safety profile of two doses of Menactra Vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None